Program Information

2015 Schedule 

Designed to blend the latest advancements in science with practical clinical approaches to patient management, PCNA’s Annual Symposium features keynote addresses, lectures and workshops presented by world-renowned authorities in cardiovascular risk reduction and disease management.

Returning this year: Wednesday afternoon Pharmacology Preconference will cover three important disease management topics. Earn 7 hours of pharmacology credit (Pre-course work and post-course evaluation required).  


Wednesday, April 8           Pharmacology Preconference

*Pharmacology Preconference may be attended as a stand-alone event   

Registration open 9:00 a.m. to 7:00 p.m.

    

                            
11:00 a.m. - 12:15 p.m.   Lunch Product Theater (non-CE)

Cholesterol Management
hosted by Kowa
     
12:30 p.m. - 12:45 p.m.   Welcome

Course Director, Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA

     
12:45 p.m. - 2:15 p.m.  

Antihyperglycemic Agents in the Treatment of Patients with Type 2 Diabetes 
Cindy Lamendola, MSN, ANP-BC, FAHA, FPCNA

     
2:30 p.m. - 3:45 p.m.  

CVD Risk Reduction with Lipid-Lowering Medications: Statins and Beyond
Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA, FAAN

     
3:45 p.m. - 5:00 p.m.   Pharmacotherapy for the Management of Heart Failure
Joanna Sikkema, DNP, MSN, ANP-BC, FAHA, FPCNA



5:00 p.m. - 5:30 p.m.   Case Studies with All Faculty Panel

Thursday, April 9       Annual Symposium

Registration open 6:30 a.m. to 7:00 p.m.

Exhibit hours are 12:10 p.m. to 2:10 p.m. and 5:00 p.m.

to 6:30 p.m. 


8:15 a.m.   Breakfast
Co-hosted by the Society for Vascular Nursing
Sponsored by Boehringer Ingelheim
     
8:30 a.m. - 9:15 a.m.  

Welcome, Awards, Annual Review, President's Address

     
9:15 a.m. - 10:15 a.m.  

Management of the Patient with VTE: A Case-Based Approach
Kelly Rudd, PharmD, BCPS, CACP
Melody Heffline, MSN, RN, ACNS-BC, ACNP-BC

     
10:25 a.m. - 11:20 a.m.  

Exercise Really IS Medicine
Robert Sallis, MD

     
11:20 a.m. - 12:10 p.m.
 

Heart Health and Brain Health: Same Formula?
Neelum Aggarwal, MD

     
12:20 p.m. - 2:05 p.m.   Exhibits
     
12:20 p.m. - 1:15 p.m.   Lunch Product Theater (non-CE)

Speak from the Heart/Angina
hosted by Gilead
     
12:15 p.m.  

Leadership Luncheon (Invitation Only)
Sponsored by General Mills

     
2:10 p.m. - 3:00 p.m.  

Race and Ethnicity: Impact on Heart Disease
Clyde Yancy, MD, MSc, FACC, FAHA, MACP

     
3:05 p.m. - 4:00 p.m.    Repeated concurrent sessions - Choose One

 

 

  Beyond Scare Tactics: Effective Risk Communication Strategies
Lola A. Coke, PhD, ACNS-BC, RN-BC, FAHA, FPCNA

Exercise is Heart Failure Medicine Too
Nancy Houston Miller, RN, BSN, FAHA, FPCNA

Management of Pregnancy in Women with Heart Disease
Mary Canobbio, MN, RN, FAAN

Moderated Poster Session I
     
4:05 p.m. - 5:00 p.m.    Repeated concurrent sessions - Choose One
     
    Beyond Scare Tactics: Effective Risk Communication Strategies
Lola A. Coke, PhD, ACNS-BC, RN-BC, FAHA, FPCNA

Exercise is Heart Failure Medicine Too
Nancy Houston Miller, RN, BSN, FAHA, FPCNA

Management of Pregnancy in Women with Heart Disease
Mary Canobbio, MN, RN, FAAN

Moderated Poster Session II
     
5:00 p.m. - 6:30 p.m.   Exhibits, Opening Reception, and Poster Presentations

 
6:45 p.m. - 7:45 p.m.   Product Theater Dinner (non-CE)

AFib and Stroke Prevention
hosted by Janssen Pharmaceuticals
     

Friday, April 10

Registration open 7:30 a.m. to 7:00 p.m.

Exhibit hours are 9:45 a.m. to 10:45 a.m. and 12:15 p.m. to 2:15 p.m.

8:15 a.m.   Breakfast
Sponsored by AstraZeneca
     
8:30 a.m. - 8:45 a.m.  

Welcome: Fellow Recognition, Poster Winners Announced

     
8:45 a.m. - 9:45 a.m.   The Post-ACS Patient: Adherence to Critical Therapies in the Shot- and Long-Term
Joseph Aragon, MD, FACC, FSCAI
Anna Borz, RN, MSN, CNP

     
9:45 a.m. - 10:45 a.m.  

Break / Exhibits Open

     
10:45 a.m. - 11:15 a.m.  

Winning Abstract Presentations 

     
11:20 a.m. - 12:15 p.m.  

What's a Clinician to do? Implementation of the 2013 Prevention Guidelines
Donald Lloyd-Jones, MD, ScM, FACC, FAHA

     
12:20 p.m. - 2:15 p.m.    Exhibits 
     
12:20 p.m. - 1:30 p.m.   Product Theater Lunch (non-CE)

Advancing Knowledge of Hypertriglyceridemia 
hosted by AstraZeneca
     
2:15 p.m. - 3:05 p.m.  

Beyond Statins: What Does the Future of Dyslipidemia Treatment Hold?
Karol Watson, MD, PhD

     
3:15 p.m. - 4:10 p.m.   Repeated concurrent sessions - Choose one
     

 

  What Can We Offer the Patient with Resistant Hypertension in 2015?
Joel Handler, MD  

Safe Transition from H2H
Kim Newlin, RN, CNS, NP-C, FPCNA

Surgical Approaches to Obesity: Long Term Impact on CV Risk
John Morton, MD, MPH, FACS, FASMBS

Cardiac Device Update: New Tools and New Indications
Robin Trupp, PhD, ACNP-BC, CHFN, FAHA
     
4:15 p.m. - 5:10 p.m.    Repeated concurrent sessions - Choose one
     
   

What Can We Offer the Patient with Resistant Hypertension in 2015?
Joel Handler, MD
  

Safe Transition from H2H
Kim Newlin, RN, CNS, NP-C, FPCNA

Surgical Approaches to Obesity: Long Term Impact on CV Risk
John Morton, MD, MPH, FACS, FASMBS

Cardiac Device Update: New Tools and New Indications
Robin Trupp, PhD, ACNP-BC, CHFN, FAHA

     

Saturday, April 11

Registration open 7:30 a.m. to 12:30 p.m.

8:00 a.m.   Breakfast
     
8:15 a.m. - 8:25 a.m.  

Welcome

     

8:25 a.m. - 9:25 a.m.

 

A Patient-Centered Approach to Lipid Management in the Complicated Patient
Co-sponsored by the FH Foundation and the National Lipid Foundation
Mary Ann Champagne, MSN, CNS, FAHA, FPCNA
Joshua W. Knowles, MD, PhD

 

 

 

9:25 a.m. - 10:10 a.m.

 

Women and Stroke: Guidelines for Prevention
Wende Fedder, RN, MBA, FAHA

 

 

 

10:15 a.m. - 11:00 a.m.

 

Menopausal Hormone Therapy and SERMS: Cardiovascular Risks and Benefits
Cynthia Stuenkel, MD, NCMP

 

 

 

11:00 a.m. - 11:45 a.m.

 

Sex and Gender Influences on CVD Management of Women 
Marcia Stefanick, PhD

 

 

 

11:45 a.m. - 12:30 p.m.

 

Pregnancy Complications are Predictors of Cardiovascular Disease in Women
Ellen Seely, MD

     
12:35 p.m.  

Closing



Provider approved by the California Board of Registered Nursing, Provider No. CEP 16268 for 16 Contact Hours.

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program is accredited for 16 contact hours of continuing education, which includes 3 hours of pharmacology. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.

Slides from 2014 Sessions

Access slides from the 2014 PCNA 20th Annual Symposium.